Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Favipiravir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 516Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Favipiravir Drug Shows Promise Against Chandipura Virus
    Favipiravir Drug Shows Promise Against Chandipura Virus

    24 Jun 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/favipiravir-drug-shows-promise-against-chandipura-virus-in-preclinical-studies-by-niv/articleshow/122045646.cms

    ECONOMICTIMES
    24 Jun 2025
    Share Share
    Tetra Bio-Pharma reports results from trial of ARDS-003 and Favipiravir
    Tetra Bio-Pharma reports results from trial of ARDS-003 and Favipiravir

    07 Dec 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/tetra-bio-pharma-trial-ards-003-favipiravir/

    CLINICALTRIALSARENA
    07 Dec 2022
    Share Share
    Appili Therapeutics Provides Update Ph3 PRESECO Clinical Trial Evaluating Avigan
    Appili Therapeutics Provides Update Ph3 PRESECO Clinical Trial Evaluating Avigan

    14 Oct 2022

    // APPILITHERAPEUTICS

    https://www.appilitherapeutics.com/newsfeed/Appili-Therapeutics-Provides-Update-on-Phase-3-PRESECO-Clinical-Trial-Evaluating-Avigan%C2%AE%2FReeqonus%E2%84%A2

    APPILITHERAPEUTICS
    14 Oct 2022
    Share Share
    Japan's Fujifilm stops work on Avigan as COVID drug
    Japan's Fujifilm stops work on Avigan as COVID drug

    14 Oct 2022

    // HEALTH ET

    https://health.economictimes.indiatimes.com/news/pharma/japans-fujifilm-stops-work-on-avigan-as-covid-drug/94857805

    HEALTH ET
    14 Oct 2022
    Share Share
    Fujifilm terminates P III enrollment for Avigan drug trial in Japan
    Fujifilm terminates P III enrollment for Avigan drug trial in Japan

    15 Mar 2022

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/25/19862/fujifilm-terminates-ph-iii-enrolment-for-avigan-drug-trial-in-japan-due-to-omicron-variant.html

    BIOSPECTRUMASIA
    15 Mar 2022
    Share Share
    Egis Favipiravir Drug Licenced for Covid-19 Treatment
    Egis Favipiravir Drug Licenced for Covid-19 Treatment

    20 Dec 2021

    // HUNGARYTODAY

    https://hungarytoday.hu/coronavirus-egis-favipiravir-drug-licenced-covid-19-treatment/

    HUNGARYTODAY
    20 Dec 2021
    Share Share